Clearpoint Neuro is a medical devices business based in the US. Clearpoint Neuro shares (CLPT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $13.64 – an increase of 4.04% over the previous week. Clearpoint Neuro employs 115 staff and has a trailing 12-month revenue of around $31.4 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $13.64 |
|---|---|
| 52-week range | $5.11 - $19.22 |
| 50-day moving average | $12.97 |
| 200-day moving average | $13.14 |
| Wall St. target price | $27.67 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.70 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $14.11 from 2025-05-09
| 1 week (2025-05-05) | 1.66% |
|---|---|
| 1 month (2025-04-11) | 23.02% |
| 3 months (2025-02-13) | -23.23% |
| 6 months (2024-11-13) | 28.86% |
| 1 year (2024-05-13) | 141.20% |
|---|---|
| 2 years (2023-05-11) | 55.05% |
| 3 years (2022-05-11) | 99.01% |
| 5 years (2020-05-11) | 289.78% |
| Revenue TTM | $31.4 million |
|---|---|
| Gross profit TTM | $19.1 million |
| Return on assets TTM | -30.16% |
| Return on equity TTM | -81.24% |
| Profit margin | -60.26% |
| Book value | $0.92 |
| Market Capitalization | $394.8 million |
TTM: trailing 12 months
We're not expecting Clearpoint Neuro to pay a dividend over the next 12 months.
Clearpoint Neuro's shares were split on a 1:40 basis on 26 July 2016 . So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Clearpoint Neuro shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Clearpoint Neuro shares which in turn could have impacted Clearpoint Neuro's share price.
Over the last 12 months, Clearpoint Neuro's shares have ranged in value from as little as $5.11 up to $19.22. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Clearpoint Neuro's is 1.039. This would suggest that Clearpoint Neuro's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N. V. ; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University.
We dug through 60 years of Berkshire Hathaway annual shareholder letters to bring you 9 lessons from Warren Buffett: “The Oracle of Omaha.”
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Thinking of switching from Moomoo? Here are 5 apps like Moomoo that offer valuable benefits
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
Here’s what you need to know about how to buy and sell stocks online in this easy to follow, step-by-step guide.